Kansas City Urology Care
Kansas City Urology Care is a physician-owned urology and oncology practice operating 29 clinics across Kansas and Missouri, serving patients with urologic cancers, BPH, kidney stones, incontinence, and men's and women's pelvic health through a 31-physician multi-specialty team.
- Company typePrivate
- Founded2008
- HeadquartersOverland Park, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Kansas City Urology Care does
Kansas City Urology Care (KCUC) is a physician-owned Professional Association headquartered in Overland Park, Kansas, operating 29 clinic locations across the Kansas City metropolitan area and outlying communities in Kansas and Missouri. The practice delivers comprehensive urologic and oncologic care across at least 13 condition segments — prostate, bladder, kidney, and testicular cancers; benign prostatic hyperplasia (BPH); kidney stones; overactive bladder; urinary incontinence; UTIs; erectile dysfunction; testosterone deficiency; Peyronie's disease; male infertility; and women's pelvic health. KCUC's clinical model combines a 31-physician multi-specialty bench (urology, radiation oncology, medical oncology, pathology) with 26 non-physician providers and hospital-based surgical delivery through affiliations with St. Luke's Health System, AdventHealth, and Overland Park Regional Medical Center.
KCUC's technology stack is built entirely on third-party OEM medical devices rather than proprietary platforms: the da Vinci Robotic Surgery System for minimally invasive prostatectomy and nephrectomy; Varian RapidArc for image-guided radiation; MRI Ultrasound Fusion Biopsy for targeted prostate cancer detection; and a broad BPH armamentarium including Aquablation Therapy (robotic waterjet), UroLift, Rezum, and Prostate Artery Embolization. Advanced bladder care is delivered via Axonics and InterStim sacral neuromodulation, and oncology offerings include PROVENGE cellular immunotherapy, brachytherapy, cryotherapy, and proton therapy accessed through the Kansas City Proton Institute partnership. The practice holds ACHC and ACR accreditations plus Centers of Excellence designations from Axonics, Teleflex/UroLift, and Boston Scientific (AMS 700).
KCUC's business model is fee-for-service clinical care billed primarily through insurance with copays collected at time of service, supplemented by a 30% self-pay discount for uninsured patients and standard no-show/returned-check fees. Revenue streams span office consultations, diagnostic testing (cystoscopy, urodynamics, imaging), in-office procedures (cystoscopy, Rezum, UroLift, Xiaflex, Bulkamid, MonaLisa Touch), and higher-acuity surgical and radiation services delivered in hospital and ambulatory settings. Go-to-market is sales-led through physician referrals, direct patient acquisition via online appointment requests and a provider-finder tool, and community outreach (e.g., the Prostate Cancer Foundation Royals Homerun Challenge). Patient engagement is supported by the St. Luke's MyChart portal, Phreesia-based card-on-file payments, and an extensive content library of condition-specific educational pages.
Kansas City Urology Care firmographics
Firmographics- Name
- Kansas City Urology Care
- Legal name
- Kansas City Urology Care, PA
- Website
- https://kcuc.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Kansas City Urology Care is a physician-owned urology and oncology practice operating 29 clinics across Kansas and Missouri, serving patients with urologic cancers, BPH, kidney stones, incontinence, and men's and women's pelvic health through a 31-physician multi-specialty team.
- Ownership category
- akta.pro rank
Kansas City Urology Care industry classification
Industry- Product category
- Urology and Oncology Medical Services
- NAICS
- Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- General Urology (HLAKAOAA)
- akta.pro secondary industries
- Urologic Oncology (HLAKAOAB), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC)
Keywords
Where Kansas City Urology Care is headquartered
LocationHeadquarters
- HQ city
- Overland Park
- HQ country
- United States
- HQ region
- North America
Offices29 records
Markets served
Kansas City Urology Care business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Services Revenue: Fee-for-service medical care billed to insurance companies and patients for urology and oncology consultations, procedures, and treatments
- Procedure and Surgical Services: Revenue from surgical procedures including robotic surgery, radiation therapy, biopsies, and minimally invasive treatments
- Diagnostic Services: Revenue from diagnostic testing including imaging, lab work, urinalysis, and specialized urologic diagnostics
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Standard office visit copay |
| Unit Pricing | Pay-as-you-go | Uninsured patient discount |
| Unit Pricing | Pay-as-you-go | No-show fees |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Kansas City Urology Care product offering
Product offeringCore offering
Kansas City Urology Care provides comprehensive urology and oncology clinical services spanning prostate, bladder, kidney, and testicular cancer diagnosis and treatment; benign prostatic hyperplasia (BPH) care; kidney stone management; urinary incontinence and overactive bladder therapy; men's reproductive health (erectile dysfunction, testosterone deficiency, Peyronie's disease, male infertility, vasectomy); and women's intimate health. Services are delivered through 20+ clinic locations and affiliated hospitals across Kansas and Missouri by 31 urologists plus radiation oncologists, medical oncologists, pathologists, and advanced practice providers, using advanced technologies including da Vinci Robotic Surgery, Aquablation, MRI Fusion Biopsy, Varian RapidArc, and proton therapy.
Product overview
Kansas City Urology Care (KCUC) is a healthcare provider offering a comprehensive portfolio of urological and oncological treatments through multiple locations in Kansas and Missouri. The practice operates as a unified clinical services platform rather than a software product, providing over 20 treatment types across cancer care, men's health, and urinary conditions. Key advanced treatments include Aquablation Therapy (robotic waterjet BPH treatment), da Vinci Robotic Surgery for minimally invasive procedures, Varian RapidArc radiation therapy, PROVENGE immunotherapy, SpaceOAR hydrogel spacers, MRI Ultrasound Fusion Biopsy for prostate cancer detection, UroLift and Rezum for BPH, Axonics/InterStim neuromodulation for overactive bladder, and comprehensive surgical services including vasectomy, incontinence surgery, and cancer treatments. The practice integrates with Phreesia for billing, MyChart patient portal, and MediCopy for medical records access.
Differentiator
Problem solved
Functional benefit
Products and services
- Aquablation Therapy Robotic-assisted surgical procedure using real-time ultrasound imaging with a heat-free, high-velocity waterjet to precisely remove prostate tissue for BPH treatment, preserving sexual function.
- da Vinci Robotic Surgery Robotic-assisted precision surgery for complex urologic cases including nerve-sparing prostatectomy, nephrectomy, and cystectomy.
- Varian RapidArc Radiation Therapy Fast, high-precision IMRT radiation therapy delivering treatments in under 2 minutes while minimizing damage to surrounding tissue.
- PROVENGE (Sipuleucel-T) Immunotherapy Personalized cellular immunotherapy using the patient's own immune system to fight advanced prostate cancer.
- SpaceOAR Hydrogel Minimally invasive hydrogel spacer placed between rectum and prostate prior to radiation therapy to protect healthy tissue.
- MRI Ultrasound Fusion Biopsy Advanced diagnostic technique that overlaps MRI images with real-time ultrasound for targeted lesion biopsy and accurate prostate cancer detection.
- UroLift Prostate Procedure Minimally invasive BPH treatment using small titanium implants to lift and hold prostate tissue away from the urethra, preserving sexual function.
- Rezum Water Vapor Therapy Minimally invasive in-office procedure using steam (water vapor) injections to treat BPH while preserving sexual function.
- Prostate Artery Embolization (PAE) Minimally invasive outpatient procedure performed by interventional radiologists to reduce prostate blood supply and shrink the gland for BPH relief.
- Axonics Sacral Neuromodulation Therapy Implanted sacral neuromodulation device that sends mild electrical pulses to the sacral nerve to treat overactive bladder and urinary incontinence.
- InterStim Neuromodulation Implanted device therapy functioning as a 'pacemaker for the bladder' that sends electrical impulses to sacral nerves to restore bladder and bowel control.
- Botox for Overactive Bladder Botulinum toxin injection into the bladder muscle for treatment of urge incontinence in patients unresponsive to traditional therapies.
- MonaLisa Touch Laser Therapy Innovative laser therapy for women's intimate health treating vaginal dryness, burning, painful intercourse, and urinary symptoms.
- Bulkamid Urethral Bulking Injectable bulking agent that provides support to the bladder neck to treat stress urinary incontinence.
- Cystectomy Surgical removal of the bladder performed for bladder cancer treatment or benign conditions.
- Nephrectomy Surgical removal of kidney tissue, partial or radical, performed laparoscopically or robotically for kidney cancer.
- Nerve-Sparing Prostatectomy Surgical technique for prostate removal that preserves nerve function to maintain erectile capability.
- Transurethral Resection of Bladder Tumor (TURBT) Surgical procedure using a cystoscope to remove bladder tumors while preserving bladder function.
- Transurethral Resection of the Prostate (TURP) Gold-standard surgical procedure for BPH that cores out the inside of the prostate using electrical current to create a larger urinary channel.
- Ureteroscopy Flexible scope procedure for kidney stone retrieval and treatment through the urethra and bladder up to the ureter.
- Percutaneous Stone Removal Minimally invasive procedure using a nephroscope placed through skin to remove larger kidney stones from the renal collection system.
- Vasectomy Permanent male sterilization procedure.
- Vasectomy Reversal (Vasovasostomy) Microscopic surgical procedure to reconnect the vas deferens and restore sperm flow after vasectomy.
- Male Incontinence Surgery Surgical treatments including artificial urinary sphincter implantation and sling procedures for male stress incontinence.
- Female Incontinence Surgery Surgical solutions including sling procedures and vaginal repairs for female urinary leakage issues.
- Urodynamics Study Diagnostic testing to examine bladder and urethral sphincter function including pressure, flow, and sphincter measurements.
- Cystoscopy Diagnostic procedure using a flexible scope inserted through the urethra to view the bladder and lower urinary tract.
- Proton Therapy Pencil-thin proton beam radiation therapy that targets cancer cells with precision while reducing risk of damage to surrounding healthy tissues, delivered via partnership with the Kansas City Proton Institute.
Quantifiable outcome
- Over 95% of testicular cancer cases can be treated successfully when detected early
- +2 more outcomes
Companies that use Kansas City Urology Care
Customer profileNamed customers1 record
Segments13 records
Ideal customer profiles2 records
Kansas City Urology Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature8 records
Kansas City Urology Care partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- Kansas City Proton InstitutecoreKCUC partnership with Kansas City Proton Institute provides patients access to cutting-edge proton radiation therapy for cancer treatment. Proton therapy offers pencil-thin beam targeting with reduced risk of damage to surrounding healthy tissues compared to traditional X-ray radiation therapy.
- Axonics, Inc.coreKCUC designated as Axonics Center of Excellence recognizing expertise with Axonics Therapy for bladder dysfunction treatment. The partnership involves specialized training and certification in sacral neuromodulation therapy.
- Teleflex (UroLift)coreKCUC designated as UroLift Center of Excellence recognizing expertise with UroLift Therapy System for BPH treatment. Partnership involves specialized training and commitment to patient education for minimally invasive prostate treatment.
- Boston Scientific (AMS 700)coreKCUC designated as AMS 700 Inflatable Penile Prosthesis Center of Excellence by Boston Scientific recognizing expertise in penile prosthesis procedures for erectile dysfunction treatment.
- St. Luke's Health SystemcoreKCUC provides urology services at St. Luke's North Hospital (Barry Road and Kansas City locations) and St. Luke's Hospital - Plaza for comprehensive patient care access.
- AdventHealthcoreKCUC provides urology services at AdventHealth/Shawnee Mission in Merriam, KS and AdventHealth/Ransom Memorial Hospital in Ottawa, KS.
- Overland Park Regional Medical CentercoreKCUC provides urology services at Overland Park Regional Medical Center in Overland Park, KS.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Kansas City Urology Care competitors and assessment
Company assessmentDirect peers
- US Urology Partners: PE-backed (General Atlantic) urology platform aggregating independent practices across multiple states. Directly comparable business model to KCUC: multi-physician urology groups, broad service lines including oncology and men's health, regional density. Most relevant strategic comp.
- United Urology Group: PE-backed (Welsh Carson) urology platform that owns Chesapeake Urology and other regional groups. Closest like-for-like comp to KCUC in scale, specialty breadth, and PE-backed consolidation model.
- Chesapeake Urology: Mid-Atlantic urology group now under United Urology Group; comparable independent-origin specialty practice with similar oncology and men's health service mix.
- Texas Urology Specialists: Large Texas-based urology network affiliated with Texas Oncology. Comparable in offering comprehensive urologic oncology and men's health across many locations, though operates under a larger oncology parent.
- Michigan Institute of Urology: Large independent urology group serving metro Detroit with comparable multi-location, multi-specialty urology services including oncology, BPH, and incontinence treatments.
- Oregon Urology Institute: Regional independent urology specialty practice offering comparable breadth including oncology, robotic surgery, men's health, and BPH treatments in a single metro market.
- Arizona Urology Specialists: Multi-location urology specialty group operating in Phoenix metro with similar oncology, BPH and men's health service lines. Comparable scale and independent group practice model.
Broad incumbents
- AdventHealth: Large nonprofit health system that partners with KCUC for inpatient and surgical services at Shawnee Mission and Ransom Memorial hospitals. Comparable as a broad incumbent in KCUC's geography with overlapping urology service capability.
- St. Luke's Health System: KCUC's largest hospital partner, providing inpatient urology coverage at Plaza and North locations. Comparable as a regional incumbent that could also employ urologists directly, representing both partnership and competitive dynamic.
- HCA Midwest Health: Hospital partner operating Overland Park Regional Medical Center where KCUC provides services. Comparable as the largest commercial hospital system in KC metro with growing employed-physician strategy that could compete with KCUC.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Kansas City Urology Care social profiles
Digital presenceKansas City Urology Care compliance and trust
Trust signalCompliance5 records
Kansas City Urology Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kansas City Urology Care leadership team
Management profileNumber of profiles
Kansas City Urology Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kansas City Urology Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kansas City Urology Care
What does Kansas City Urology Care do?
Kansas City Urology Care provides comprehensive urology and oncology clinical services spanning prostate, bladder, kidney, and testicular cancer diagnosis and treatment; benign prostatic hyperplasia (BPH) care; kidney stone management; urinary incontinence and overactive bladder therapy; men's reproductive health (erectile dysfunction, testosterone deficiency, Peyronie's disease, male infertility, vasectomy); and women's intimate health. Services are delivered through 20+ clinic locations and affiliated hospitals across Kansas and Missouri by 31 urologists plus radiation oncologists, medical oncologists, pathologists, and advanced practice providers, using advanced technologies including da Vinci Robotic Surgery, Aquablation, MRI Fusion Biopsy, Varian RapidArc, and proton therapy.
Is Kansas City Urology Care a public or private company?
Kansas City Urology Care is a private company. It is classified as management employee owned and is currently operating.
When was Kansas City Urology Care founded?
Kansas City Urology Care was founded in 2008. It employs 101 to 250 people.
Where is Kansas City Urology Care based?
Kansas City Urology Care is headquartered in Overland Park, United States, in the North America region.
How does Kansas City Urology Care make money?
Three revenue lines are on record. Medical Services Revenue is the primary driver. The others are procedure and Surgical Services and diagnostic Services.
Who are Kansas City Urology Care's main competitors?
Direct peers on record are US Urology Partners, United Urology Group, Chesapeake Urology, Texas Urology Specialists, Michigan Institute of Urology, Oregon Urology Institute and Arizona Urology Specialists. Broad incumbents are AdventHealth, St. Luke's Health System and HCA Midwest Health.
Does Kansas City Urology Care have an API?
No public API is recorded for Kansas City Urology Care.
What industry is Kansas City Urology Care in?
Kansas City Urology Care's product category is Urology and Oncology Medical Services. Its primary akta.pro industry code is HLAKAOAA, General Urology, with a secondary code of HLAKAOAB, Urologic Oncology. Its NAICS code is 62111 and its SIC code is 8011.